1600 patients with severe, end stage renal disease or post transplant will be randomised 1:1:1 to either standard therapeutic education; or education using a specific app; or the enhanced interactive app using feedback messages. The total follow up duration is 18 months. Primary endpoint is the cost utility of using app-based therapeutic intervention, secondary endpoints are: compliance with treatment guidelines, app use (professionals and patients), budget impact analysis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
1,600
Patients will connect to a platform providing information on end-stage renal disease and to contact health care providers.
Patients in the enhanced app group will also have access to a social network. (forum, chat room)
cost utility, efficiency, budget impact
incremental cost utility ratio
Time frame: 18 months
overall survival
percent of patients alive at 18 months
Time frame: 18 months
compliance and persistence
percent of patients using the app at 18 months
Time frame: 18 months
disease knowledge
answers to a questionnaire and change in the number of correct answers
Time frame: 18 months
lifestyle
changes in risk factors
Time frame: 18 months
app utilization by professionals and patients
number of connections, shares, likes
Time frame: 18 months
health care delivery organization
number of interactions (chats) between healthcare professionals and patients
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.